✦ LIBER ✦

Natalizumab and drug holiday in clinical practice: An observational study in very active relapsing remitting Multiple Sclerosis patients

✍ Scribed by A. Kerbrat; E. Le Page; E. Leray; T. Anani; M. Coustans; C. Desormeaux; C. Guiziou; P. Kassiotis; F. Lallement; D. Laplaud; P. Diraison; F. Rouhart; E. Sartori; R. Wardi; S. Wiertlewski; G. Edan

Book ID: 118055753
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 347 KB
Volume: 308
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2011.05.043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of natalizumab

Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study

✍ F. Sangalli; L. Moiola; S. Bucello; P. Annovazzi; A. Rizzo; M. Radaelli; G. Vite 📂 Article 📅 2010 🏛 Springer Milan 🌐 English ⚖ 238 KB

Clinical parameters and HHV-6 active rep

Clinical parameters and HHV-6 active replication in relapsing—remitting multiple sclerosis patients

✍ Roberto Álvarez-Lafuente; Marta García-Montojo; Virginia De Las Heras; Manuel Ba 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

✍ Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; C 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 170 KB

Effect of natalizumab on clinical and ra

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

✍ Melin, A.; Outteryck, O.; Collongues, N.; Zéphir, H.; Fleury, M. C.; Blanc, F.; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 305 KB

Longitudinal study of antimyelin T-cell

Longitudinal study of antimyelin T-cell reactivity in relapsing–remitting multiple sclerosis: association with clinical and MRI activity

✍ Niels Hellings; Geert Gelin; Robert Medaer; Liesbeth Bruckers; Yvan Palmers; Jef 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 742 KB

PND13 A COST-EFFECTIVENESS ANALYSIS OF N

PND13 A COST-EFFECTIVENESS ANALYSIS OF NATALIZUMAB VS. INTERFERON-BETA AND GLATIRAMER ACETATE IN PATIENTS WITH ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS CURRENTLY FAILING ON EXISTING THERAPY

✍ R Gani; ER Samuels; S Hughes; G Giovanonni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB